Cost-effectiveness analysis of five drugs for treating postmenopausal women in the United States with osteoporosis and a very high fracture risk

Incidence and Economic Burden of Osteoporosis-Related Fractures in the United States, 2005–2025

Russel Burge, Bess Dawson‐Hughes, Daniel H. Solomon et al. · Journal of Bone and Mineral Research · 2006 · 4K citations

Public Health, Orthopedic Surgery, Population Health Sciences +16

Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses

Gillian D Sanders, Peter J. Neumann, Anirban Basu et al. · JAMA · 2016 · 3K citations · Full text

Pharmacy, Health Administration, Health Policy +17

Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group.

PubMed · 1994 · 2.5K citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +16

Markov Models in Medical Decision Making

Frank A. Sonnenberg, J. Robert Beck · Medical Decision Making · 1993 · 2.4K citations

Business, Decision Sciences, Clinical Decision Support +16

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement

Don Husereau, Michael Drummond, Stavros Petrou et al. · BMJ · 2013 · 1.8K citations · Full text

Public Affairs, Health Policy, Pharmacoeconomics +16